Wall Street analysts expect Medical Transcription Billing Corp (NASDAQ:MTBC) to announce ($0.23) earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Two analysts have issued estimates for Medical Transcription Billing’s earnings, with the lowest EPS estimate coming in at ($0.24) and the highest estimate coming in at ($0.22). Medical Transcription Billing posted earnings per share of ($0.03) during the same quarter last year, which indicates a negative year over year growth rate of 666.7%. The firm is expected to issue its next earnings results on Monday, November 5th.

On average, analysts expect that Medical Transcription Billing will report full year earnings of ($0.50) per share for the current year, with EPS estimates ranging from ($0.61) to ($0.38). For the next financial year, analysts anticipate that the company will post earnings of ($0.20) per share, with EPS estimates ranging from ($0.27) to ($0.13). Zacks Investment Research’s earnings per share averages are an average based on a survey of research firms that cover Medical Transcription Billing.

Medical Transcription Billing (NASDAQ:MTBC) last announced its earnings results on Wednesday, August 8th. The technology company reported ($0.09) EPS for the quarter, meeting the Zacks’ consensus estimate of ($0.09). Medical Transcription Billing had a negative net margin of 2.73% and a positive return on equity of 2.01%. The firm had revenue of $8.68 million for the quarter, compared to analysts’ expectations of $8.39 million.

Separately, HC Wainwright set a $6.00 price target on shares of Medical Transcription Billing and gave the stock a “buy” rating in a research note on Monday, July 2nd. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus target price of $3.92.

Shares of MTBC stock opened at $4.45 on Tuesday. The firm has a market cap of $55.09 million, a PE ratio of -34.23 and a beta of 1.73. Medical Transcription Billing has a 12 month low of $1.39 and a 12 month high of $5.44.

In related news, CFO Bill Korn sold 5,000 shares of the company’s stock in a transaction dated Wednesday, July 25th. The shares were sold at an average price of $5.01, for a total value of $25,050.00. Following the transaction, the chief financial officer now owns 152,800 shares in the company, valued at approximately $765,528. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, General Counsel Shruti H. Patel sold 12,291 shares of the company’s stock in a transaction dated Wednesday, September 12th. The stock was sold at an average price of $4.61, for a total transaction of $56,661.51. The disclosure for this sale can be found here. In the last quarter, insiders sold 27,491 shares of company stock worth $129,712. 49.70% of the stock is currently owned by company insiders.

A hedge fund recently bought a new stake in Medical Transcription Billing stock. Dimensional Fund Advisors LP bought a new stake in shares of Medical Transcription Billing Corp (NASDAQ:MTBC) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 27,909 shares of the technology company’s stock, valued at approximately $108,000. Dimensional Fund Advisors LP owned 0.24% of Medical Transcription Billing as of its most recent filing with the Securities and Exchange Commission. 5.84% of the stock is currently owned by hedge funds and other institutional investors.

About Medical Transcription Billing

Medical Transcription Billing, Corp. is a healthcare information technology company that provides an integrated suite of Web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. The Company’s offering, PracticePro, allows healthcare practices with the core software and business services on Software-as-a-Service (SaaS) platform.

Read More: Risk Tolerance

Get a free copy of the Zacks research report on Medical Transcription Billing (MTBC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Medical Transcription Billing Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Transcription Billing and related companies with MarketBeat.com's FREE daily email newsletter.